|Manufacturer:||TEVA PHARMACEUTICALS USA|
Manufactured In Israel By:
TEVA PHARMACEUTICAL IND.
Jerusalem, 91010, Israel
TEVA PHARMACEUTICALS USA
Sellersville, PA 18960
Carvedilol is an alpha/beta-adrenergic blocking agent indicated for the treatment of:
Left ventricular dysfunction following myocardial infarction in clinically stable patients (1.1)
Left Ventricular Dysfunction
-- A condition in which the LEFT VENTRICLE of the heart was functionally impaired. This condition usually leads to HEART FAILURE; MYOCARDIAL INFARCTION; and other cardiovascular complications. Diagnosis is made by measuring the diminished ejection fraction and a depressed level of motility of the left ventricular wall.
-- NECROSIS of the MYOCARDIUM caused by an obstruction of the blood supply to the heart (CORONARY CIRCULATION).
-- Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more.
Carvedilol is contraindicated in the following conditions:
Bronchial asthma or related bronchospastic conditions.
Deaths from status asthmaticus have been reported following single doses of carvedilol.
Second- or third-degree AV block
Sick sinus syndrome
Severe bradycardia (unless a permanent pacemaker is in place)
Patients with cardiogenic shock or who have decompensated heart failure requiring the use of intravenous inotropic therapy.
Such patients should first be weaned from intravenous therapy before initiating carvedilol
Patients with clinically manifest hepatic impairment
Patients with a history of a serious hypersensitivity reaction to carvedilol (e.g., Stevens-Johnson syndrome)
-- A form of bronchial disorder with three distinct components: airway hyper-responsiveness (RESPIRATORY HYPERSENSITIVITY), airway INFLAMMATION, and intermittent AIRWAY OBSTRUCTION. It is characterized by spasmodic contraction of airway smooth muscle, WHEEZING, and dyspnea (DYSPNEA, PAROXYSMAL).
-- A sudden intense and continuous aggravation of a state of asthma, marked by dyspnea to the point of exhaustion and collapse and not responding to the usual therapeutic efforts.
-- Shock resulting from diminution of cardiac output in heart disease.
-- Altered reactivity to an antigen, which can result in pathologic reactions upon subsequent exposure to that particular antigen.
-- A variant of bullous erythema multiforme. It ranges from mild skin and mucous membrane lesions to a severe, sometimes fatal systemic disorder. Ocular symptoms include ulcerative conjunctivitis, keratitis, iritis, uveitis, and sometimes blindness. The cause of the disease is unknown.
The following US Branded drugs contain Carvedilol
-- SMITHKLINE BEECHAM CORP DBA GLAXOSMITHKLINE
This web-site is for informational purposes only and is not intended as a substitute for advice from your doctor.
It should not to be used for self-diagnosis or treatment.